Background: The present study documents the natural history and outcomes of high-risk
bladder cancer after radical cystectomy (RC) in patients who did not receive neoadjuvant …

Study Type–Therapy (case series) Level of Evidence 4 OBJECTIVE To evaluate data
obtained from a large, multi‐institutional, contemporary series of patients who underwent …

Background: Benefits of adjuvant chemotherapy (AC) and extent of pelvic lymph node
dissection (PLND) in radical cystectomy (RC) are debated. Results from randomized trials …

Purpose: We assessed survival dependent on pathological response after neoadjuvant
chemotherapy in a large multicenter patient cohort, with a particular focus on the difference …

Objectives We investigated the clinical outcomes of radical cystectomy without cisplatin‐
based neoadjuvant chemotherapy (NAC) and identified factors affecting the effectiveness of …

OBJECTIVE To analyse the outcome after radical cystectomy (RC) in patients with clinical T2
bladder cancer not responding to neoadjuvant chemotherapy (NAC). PATIENTS AND …

Background Induction chemotherapy (IC) for clinically node-positive bladder cancer is
applied without clinical evidence of improved outcome. Our objective was to compare …

Study Type–Therapy (case series) Level of Evidence 4 What's known on the subject? and
What does the study add? Radical cystectomy with bilateral pelvic lymph node dissection is …

Object: To elucidate the impact of adjuvant chemotherapy (ACH) on survival in patients with
urothelial carcinoma of the bladder (UCB) diagnosed with pT3 disease (perivesical tissue …

This retrospective study compared adjuvant chemotherapy (AC) versus observation after
radical cystectomy (RC) in patients with node-positive bladder cancer (pN+). Outcomes were …